检索系统基础训练研讨会课件.ppt

1、2022/12/151STN 檢索系統基礎訓練研討會檢索系統基礎訓練研討會日期：2000年8月15日主辦單位：工研院化工所主講人：吳清源永光化學智權中心2022/12/152講題大綱講題大綱-下午下午nSTN Commands(下午13:30-16:30)n多種資料庫檢索(Multi-file Search Strategies)n實機線上練習(Skill Practices)nSTN進階檢索指令(STN Commands Reviews)n實機線上練習(Skill Practices)nL-Numbers使用技巧介紹(Working With L-Numbers)n實機線上練習(Skill

2、Practices)2022/12/153Multi-file Search Strategiesn如果要一次檢索多個資料庫，有以下方法：n簡單的使用FILE filename1 filename2 filename3 nSET MSTEPS ONn直接使用系統預設群組(clusters)n修改系統預設群組以適合您的需求n自己將想要的資料庫設定為群組2022/12/154=FILE LCA LMEDLINE LDRUG=E CYTOTECE1 1 CYTOTACTIN/BIE2 1 CYTOTAXONOMY/BIE3 1-CYTOTEC/BIE4 1 CYTOTEC*RC/BI。E12 394

3、 CYTOTOXICITY/BI=S E3L2 1 CYTOTEC/BI=SET MSTEPS ONSET COMMAND COMPLETED=S CYTOTECL3 0 FILE LCA L4 0 FILE LMEDLINE L5 1 FILE LDRUG TOTAL FOR ALL FILESL6 1 CYTOTECSET MSTEPS ON後後會顯示每一個資料庫會顯示每一個資料庫所找到的資料數目所找到的資料數目簡單的使用簡單的使用FILE2022/12/155使用系統預設的群組使用系統預設的群組(clusters)nSTN系統預設51個群組(參閱CAS Catalog)n(Agricul

4、ture,Bioscience,Business Toxicology)n=D cluster bioscience=DISPLAY CLUSTER BIOSCIENCECLUSTER NAME CLUSTER DEFINITION-BIOSCIENCE ADISALERTS ADISINSIGHT AGRICOLA AIDSLINE ANABSTR AQUASCI BIOBUSINESS BIOCOMMERCE BIOSIS BIOTECHABS BIOTECHDS BIOTECHNO CABA CANCERLIT CAPLUS CEABA CEN CIN CONFSCI CROPB CRO

5、PU DDFB DDFU DGENE DRUGB DRUGLAUNCH DRUGMONOG DRUGMONOG2 DRUGNL DRUGU EMBAL EMBASE ESBIOBASE FOMAD FOREGE FROSTI FSTA GENBANK HEALSAFE IFIPAT JICST-EPLUS KOSMET LIFESCI MEDICONF MEDLINE NIOSHTIC NTIS OCEAN PHAR PHIC PHIN PROMT SCISEARCH TOXLINE TOXLIT USPATFULL WPIDS WPINDEX Bioscience Literature Cl

6、uster 2022/12/156=FILE BIOSCIENCE=SET MSTEPS ONSET COMMAND COMPLETED=S ZOMIGL1 55 FILE ADISALERTS L2 1 FILE ADISINSIGHT L3 0 FILE AGRICOLA L4 0 FILE AIDSLINE L5 0 FILE ANABSTR L6 0 FILE AQUASCI L7 18 FILE BIOBUSINESS L8 1 FILE BIOCOMMERCE L9 41 FILE BIOSIS L10 0 FILE BIOTECHABS L11 8 FILE BIOTECHNO

7、L12 0 FILE CABA L13 1 FILE CANCERLIT L14 11 FILE CAPLUS L15 0 FILE CEABA L16 0 FILE CEN L17 28 FILE CIN L18 6 FILE CONFSCI 。L29 95 FILE EMBASE L30 12 FILE ESBIOBASE L31 0 FILE FOMAD L32 0 FILE FOREGEL50 34 FILE TOXLINE L51 11 FILE TOXLIT L52 0 FILE USPATFULL L53 0 FILE WPINDEX TOTAL FOR ALL FILESL54

8、 786 ZOMIG2022/12/157修改系統預設群組修改系統預設群組n=SET CLUSTERn.cluster name 使用(.)以區隔預設群組n-cluster name 使用(-)減去不要的資料庫n輸入file name 將需要的資料庫加到.cluster2022/12/158=SET CLUSTERENTER CLUSTER NAME OR(?):BIOSCIENCEBIOSCIENCE IS NOT A VALID CLUSTER NAMEA valid cluster must:1.Begin with a period,2.Have 2-16 characters,3.C

9、ontain only letters(A-Z)and numbers(0-9)ENTER CLUSTER NAME OR(?):.BIOSCIENCEENTER LIST OF FILE NAMES OR(?):BIOSCIENCE AQUASCI,-BIOBUSINESS,-BIOCOMMERCE,-BIOSIS,-BIOTECHABSMORE FILES,(NONE)OR?:HCAPLUSMORE FILES,(NONE)OR?:NONECLUSTER.BIOSCIENCE DEFINED AS BIOSCIENCE,-AQUASCI,-BIOBUSINESS,-BIOCOMMERCE,

10、-BIOSIS,-BIOTECHABS,HCAPLUS,SET COMMAND COMPLETED2022/12/159將想要的資料庫設定為群組將想要的資料庫設定為群組n=SET CLUSTERn.cluster name(self define)以區隔預設群組n輸入file name 將需要的資料庫加到.cluster2022/12/1510=SET CLUSTERENTER CLUSTER NAME OR(?):.DRUGENTER LIST OF FILE NAMES OR(?):DRUGLAUNCH,DRUGMONOG2,DRUGNL,DRUGUMORE FILES,(NONE)OR?

11、:NONECLUSTER.DRUG DEFINED AS DRUGLAUNCH,DRUGMONOG2,DRUGNL,DRUGUSET COMMAND COMPLETED=SET MSTEPS ONSET COMMAND COMPLETED=FILE.DRUGSCOST IN U.S.DOLLARS SINCE FILE TOTAL ENTRY SESSIONFULL ESTIMATED COST 0.21 0.21FILE DRUGLAUNCH ENTERED AT 23:13:13 ON 13 AUG 2000COPYRIGHT(C)2000 IMSWORLD Publications Lt

12、dFILE DRUGMONOG2 ENTERED AT 23:13:13 ON 13 AUG 2000COPYRIGHT(C)2000 IMSWORLD Publications LtdFILE DRUGNL ENTERED AT 23:13:13 ON 13 AUG 2000COPYRIGHT(C)2000 IMSWORLD Publications LtdFILE DRUGU ACCESS NOT AUTHORIZED=S ZOMIGL1 39 FILE DRUGLAUNCH L2 35 FILE DRUGMONOG2 L3 22 FILE DRUGNL TOTAL FOR ALL FIL

13、ESL4 96 ZOMIG2022/12/1511Using DUPLICATE commandnDUPLICATE指令的作用na)將群組中重複的資料剔除=DUPLICATE Removenb)只顯示重複的資料=DUPLICATE Only2022/12/1512=FILE CAPLUS MEDLINECOST IN U.S.DOLLARS SINCE FILE TOTAL ENTRY SESSIONFULL ESTIMATED COST 0.21 1.47FILE MEDLINE ENTERED AT 23:20:49 ON 13 AUG 2000=SET MSTEPS ONSET COMM

14、AND COMPLETED=S ZOMIGL1 11 FILE CAPLUS L2 25 FILE MEDLINE TOTAL FOR ALL FILESL3 36 ZOMIG=DUPLICATE REMOVEENTER L#LIST OR(END):L3DUPLICATE PREFERENCE IS CAPLUS,MEDLINEKEEP DUPLICATES FROM MORE THAN ONE FILE?Y/(N):NPROCESSING COMPLETED FOR L3 L4 27 DUPLICATE REMOVE L3(9 DUPLICATES REMOVED)2022/12/1513

15、=DUPLICATE ONLY L3PROCESSING COMPLETED FOR L3 L5 18 DUPLICATE ONLY L3=D BIB 1-5 L5 L5 ANSWER 1 OF 18 MEDLINE DUPLICATE 1AN 2000104504 MEDLINEDN 20104504TI A long-term study to maximise migraine relief with zolmitriptan.AU Tepper S J;Donnan G A;Dowson A J;Bomhof M A;Elkind A;Meloche J;Fletcher P E;Mi

16、llson D SCS The Polyclinic,Seattle,USA.SO CURRENT MEDICAL RESEARCH AND OPINION,(1999)15(4)254-71.Journal code:DUX.ISSN:0300-7995.CY ENGLAND:United KingdomDT (CLINICAL TRIAL)Journal;Article;(JOURNAL ARTICLE)(MULTICENTER STUDY)(RANDOMIZED CONTROLLED TRIAL)LA EnglishFS Priority JournalsEM 200004EW 2000

17、0403L5 ANSWER 2 OF 18 CAPLUS COPYRIGHT 2000 ACS DUPLICATE 1AN 2000:92708 CAPLUSDN 132:117473TI A long-term study to maximize migraine relief with zolmitriptanAU Tepper,Stewart J.;Donnan,Geoffrey A.;Dowson,Andrew J.;Bomhof,Martin A.M.;Elkind,Arthur;Meloche,Jacques;Fletcher,Pamela E.;Millson,David S.C

18、S The Polyclinic,Seattle,USASO Curr.Med.Res.Opin.(1999),15(4),254-271 CODEN:CMROCX;ISSN:0300-7995PB LibraPharm Ltd.DT JournalLA English2022/12/1514Using INDEX commandnINDEX指令的作用nSTN INDEX是一個使用多重資料庫檢索時，用來預視檢索策略所得的答案總數。nINDEX的所花費用會比使用多重資料庫搜尋便宜，只要花連線費用US$45/HR。n配合=D RANK可依資料數量排名顯示。2022/12/1515=INDEX BI

19、OSCIENCEFILE DRUGMONOG ACCESS NOT AUTHORIZEDCOST IN U.S.DOLLARS SINCE FILE TOTAL ENTRY SESSIONFULL ESTIMATED COST 0.63 0.63INDEX ADISALERTS,ADISINSIGHT,AGRICOLA,AIDSLINE,ANABSTR,AQUASCI,BIOBUSINESS,BIOCOMMERCE,BIOSIS,BIOTECHABS,BIOTECHDS,BIOTECHNO,CABA,CANCERLIT,CAPLUS,CEABA,CEN,CIN,CONFSCI,CROPB,CR

20、OPU,DDFB,DDFU,DGENE,DRUGB,DRUGLAUNCH,DRUGMONOG2,.ENTERED AT 23:27:09 ON 13 AUG 200057 FILES IN THE FILE LIST IN STNINDEX Enter SET DETAIL ON to see search term postings or to viewsearch error messages that display as 0*with SET DETAIL OFF.=S ZOMIG 55 FILE ADISALERTS 1 FILE ADISINSIGHT 18 FILE BIOBUS

21、INESS 1 FILE BIOCOMMERCE 41 FILE BIOSIS 8 FILE BIOTECHNO 11 FILE CAPLUS 。22 FILE DRUGNL 11 FILE DRUGU 1 FILE LIFESCI 42 FILES SEARCHED.25 FILE MEDLINE 1 FILE PHAR 。192 FILE PROMT 45 FILE SCISEARCH 34 FILE TOXLINE 11 FILE TOXLIT 26 FILES HAVE ONE OR MORE ANSWERS,57 FILES SEARCHED IN STNINDEX L1 QUE Z

22、OMIG 2022/12/1516=D RANKF1 192 PROMT F2 95 EMBASE F3 91 PHIN F4 55 ADISALERTS F5 45 SCISEARCH F6 41 BIOSIS F7 39 DRUGLAUNCH F8 35 DRUGMONOG2 F9 34 TOXLINE F10 28 CIN F11 25 MEDLINE F12 22 DRUGNL F13 18 BIOBUSINESS F14 12 ESBIOBASE F15 11 CAPLUS F16 11 DDFU F17 11 DRUGU F18 11 TOXLIT F19 8 BIOTECHNO

23、F20 6 CONFSCI F21 2 PHIC F22 1 ADISINSIGHT F23 1 BIOCOMMERCE F24 1 CANCERLIT F25 1 LIFESCI F26 1 PHAR =FILE CAPLUS MEDLINECOST IN U.S.DOLLARS SINCE FILE TOTAL ENTRY SESSION=S L1L2 36 L12022/12/1517實機線上練習實機線上練習(Skill Practices)nQuestion 1:請同時在LCA、LMEDLINE及LDRUG資料庫中，檢索出有關於控制糖尿病併發症的相關研究(control of diab

24、etic complications)剔除其中重複的資料，再顯示其重複的資料。2022/12/1518實機線上練習實機線上練習(Skill Practices)nQuestion 2:請在Chemistry cluster中，使用INDEX檢索出關於(orange juice AND(remove AND bitter)OR(debitter)，並顯示其資料數量對資料庫的排序(RANK)，再剔除其中重複的資料，並以ALL格式顯示前兩筆專利資料。2022/12/1519STN進階檢索指令進階檢索指令n儲存答案集n儲存SAVE、顯示D SAVED、取出ACTIVATE(ACT)、刪除DELETE(

25、DEL)n排列檢索答案nSORT,ANALYZINGn將答案中欄位縮寫以全名顯示nDISPLAY L#IBIB(IALL)n顯示查詢過的答案集nDISPLAY HISTORY(D HIS),DELETE HISTORY(DEL HIS)2022/12/1520儲存答案集儲存答案集-SAVEn儲存SAVEnSAVE/A(Answer),SAVE/L(L#)nSAVE TEMP(免費但只是暫時性的儲存，保留7天後系統自動刪除)n顯示D SAVEDn取出ACTIVATE(ACT)n刪除DELETE(DEL)2022/12/1521=S ULCER#AND DRUG#54 ULCER#1334 DRU

26、G#L1 8 ULCER#AND DRUG#=SAVE TEMP L1 ULCER/AANSWER SET L1 HAS BEEN SAVED AS ULCER/A=D SAVEDNAME CREATED NOTES/TITLE-GELNUMBER/L TEMP 2 L-NUMBERS ULCER/A TEMP 8 ANSWERS IN FILE LCA =S HYPERTENSION?L2 141 HYPERTENSION?=SAVE TEMP L2 HYPER/LL#LIST L2 HAS BEEN SAVED AS HYPER/L=D SAVEDNAME CREATED NOTES/TI

27、TLE-GELNUMBER/L TEMP 2 L-NUMBERS HYPER/L TEMP 1 L-NUMBER ULCER/A TEMP 8 ANSWERS IN FILE LCA=LOGOFF2022/12/1522=FILE LCA=D SAVEDNAME CREATED NOTES/TITLE-GELNUMBER/L TEMP 2 L-NUMBERS HYPER/L TEMP 1 L-NUMBER ULCER/A TEMP 8 ANSWERS IN FILE LCA =ACTIVATE ULCER/AL1 8 SEA FILE=LCA ULCER#AND DRUG#=D L1 1 BI

28、B L1 ANSWER 1 OF 8 LCA COPYRIGHT 2000 ACSAN 101:83907 LCATI General pharmacological studies on arotinolol(S-596),a .beta.-adrenoceptor blocking drugAU Hara,Youichi;Miyagishi,Akira;Koga,Yoshihiko;Hirose,Akira;Tanaka,YukikoCS Takarazuka Res.Cent.,Sumitomo Chem.Co.Ltd.,Takarazuka,665,JapanSO Oyo Yakuri

29、(1984),27(6),1037-57 CODEN:OYYAA2;ISSN:0369-8033DT JournalLA Japanese2022/12/1523=D SAVEDNAME CREATED NOTES/TITLE-GELNUMBER/L TEMP 2 L-NUMBERS HYPER/L TEMP 1 L-NUMBER ULCER/A TEMP 9 ANSWERS IN FILE LCA =DEL HYPER/LDELETE HYPER/L?(Y)/N:Y=DEL ULCER/ADELETE ULCER/A?(Y)/N:Y=D SAVEDNAME CREATED NOTES/TIT

30、LE-GELNUMBER/L TEMP 2 L-NUMBERS 2022/12/1524排列檢索答案排列檢索答案nSORTn格式=SORT L#extraction field answer or term numbersn例子=SORT L1 AU 1-nextraction field:nAU(author)nTI(Title)nJT(Journal Title)nCS(Corporate Source)nPA(Patent Assignee)2022/12/1525=FILE LCA=S HYPERTENSION?L1 141 HYPERTENSION?=SORT L1 CS 1-PRO

31、CESSING COMPLETED FOR L1 L2 141 SORT L1 1-CS=D L2 CS 1-5 L2 ANSWER 1 OF 141 LCA COPYRIGHT 2000 ACSCS 2nd Dep.Intern.Med.,Kanazawa Univ.,Kanazawa,Japan L2 ANSWER 2 OF 141 LCA COPYRIGHT 2000 ACSCS Austin Hosp.,Univ.Melbourne,Heidelberg,3084,Australia L2 ANSWER 3 OF 141 LCA COPYRIGHT 2000 ACSCS Austral

32、as.Drug Inf.Serv.,Auckland,N.Z.L2 ANSWER 4 OF 141 LCA COPYRIGHT 2000 ACSCS Azerb.Med.Inst.,Baku,USSR L2 ANSWER 5 OF 141 LCA COPYRIGHT 2000 ACSCS Baker Med.Res.Inst.,Monash Univ.,Melbourne,Australia 2022/12/1526ANALYZINGn格式=ANALYZE L#extraction field answer or term numbersn例子=ANALYZE L1 AU 1-nextract

33、ion field*:nAU(author)nTI(Title)nJT(Journal Title)nCS(Corporate Source)nPA(Patent Assignee)*Database dependable2022/12/1527=ANALYZE L1 AU 1-L2 ANALYZE L1 1-AU:445 TERMS=D L2 1-15L2 ANALYZE L1 1-AU:445 TERMSTERM#OCC#DOC%DOC AU-1 4 4 2.84 SCHMITT,HENRI 2 3 3 2.13 LAUBIE,MICHEL 3 2 2 1.42 DOYLE,A.E.4 2

34、 2 1.42 HUTCHINSON,J.S.5 2 2 1.42 MENDELSOHN,F.A.O.6 2 2 1.42 PACE-ASCIAK,C.R.7 2 2 1.42 SEIDEL,C.L.8 2 2 1.42 TARAZI,ROBERT C.9 1 1 0.71 ABASKULIEVA,L.I.10 1 1 0.71 ABE,KEISHI 11 1 1 0.71 ABESADZE,I.G.12 1 1 0.71 AKHVLEDIANI,R.N.13 1 1 0.71 ALLAIS,ANDRE 14 1 1 0.71 ALLEN,J.C.15 1 1 0.71 ANDERSON,ST

35、EVEN C.2022/12/1528STN進階檢索指令進階檢索指令n將答案中欄位縮寫以全名顯示nDISPLAY L#IBIB(IALL)n顯示查詢過的答案集nDISPLAY HISTORY(D HIS),DELETE HISTORY(DEL HIS)2022/12/1529=D L1 IBIB 1 L1 ANSWER 1 OF 141 LCA COPYRIGHT 2000 ACSACCESSION NUMBER:101:96930 LCATITLE:Hypertension among workers in a plant for the primary production of zinc

36、AUTHOR(S):Boscolo,P.;Bergamaschi,A.;Carelli,G.;Sperduto,B.;Finelli,V.N.CORPORATE SOURCE:Inst.Occup.Med.,Cathol.Univ.Rome,Rome,ItalySOURCE:Heavy Met.Environ.,Int.Conf.,4th(1983),Volume 1,513-16.CEP Consult.:Edinburgh,UK.CODEN:51UDABDOCUMENT TYPE:ConferenceLANGUAGE:English=DISPLAY HISTORYENTER(BRIEF)O

37、R FULL:FULLENTER(L1-),L#,OR?:L1-(FILE HOME ENTERED AT 23:55:08 ON 13 AUG 2000)FILE LCA ENTERED AT 23:55:20 ON 13 AUG 2000L1 141 SEA HYPERTENSION?L2 141 SORT L1 1-CSL3 141 SEA L2L4 ANALYZE L1 1-AU:445 TERMS D L1 IBIB 1 D L1 IALL 22022/12/1530實機線上練習實機線上練習(Skill Practices)nQuestion 3:請同時在LCA、LMEDLINE及L

38、DRUG資料庫中，檢索出關於抑制偏頭痛(Antimigraine)的藥物，並以SAVE TEMP儲存查詢答案，LOGOFF 後再LOGIN，顯示儲存的資料並將其ACTIVATE，並顯示其資料數量對資料庫的排序，再剔除其中重複的資料，再以作者名稱SORT答案，以IBIB顯示前5筆資料，再以ANALYZE找出公司排名，顯示公司排名，刪除儲存的答案，確認無儲存的資料後，顯示查詢過的答案集，LOGOFF HOLD。2022/12/1531L-Numbers使用技巧介紹使用技巧介紹nWorking With L-NumbersnRe-using in the Same DatabasenRe-using

39、 in the Different DatabasenREGISTRY L-Numbered Answer Sets2022/12/1532Re-using in the Same DatabasenRe-using in the Same DatabasenCombining the L#with other search termsn=S L1 AND TERM AnCombining the L#with other L#n=S L1 AND L2nRe-searching an L#2022/12/1533=FILE LCA=S HYPERTENSION?L1 141 HYPERTEN

40、SION?=S L1 AND DRUG#1334 DRUG#L2 16 L1 AND DRUG#=E MERCK/CSE1 1 MERCH/CSE2 1 MERCHANTS/CSE3 69-MERCK/CSE4 12 MERCK AND CO INC/CSE5 5 MERCK AND CO INC USA/CSE6 2 MERCK E A G/CSE7 2 MERCK INST THER RES MERCK SHARP AND DOHME RES LAB WEST POINT PA 19486 USA/CSE8 2 MERCK INST THER RES RAHWAY NJ 07065 USA

41、/CSE9 2 MERCK INST THER RES WEST POINT PA USA/CSE10 3 MERCK PATENT G M B H/CSE11 2 MERCK PATENT G M B H FED REP GER/CSE12 1 MERCK SHARP AND DOHME RES LAB DIV MERCK AND CO INC RAHWAY NJ USA/CS=S E3-E6 69 MERCK/CS 12 MERCK AND CO INC/CS 5 MERCK AND CO INC USA/CS 2 MERCK E A G/CSL3 69(MERCK/CS OR MERCK

42、 AND CO INC/CS OR MERCK AND CO INC USA/CS OR MERCK E A G/CS)=S L1 AND L3L4 1 L1 AND L32022/12/1534Re-using in the Different DatabasenRe-using in the Different DatabasenCombining the L#with other search termsn=S L2 AND TERM AnCombining the L#with L#generated in the current databasen=S L1 OR L62022/12

43、/1535=FILE LCA=S ULCER#AND DRUG#54 ULCER#1334 DRUG#L1 8 ULCER#AND DRUG#=FILE LMEDLINE=S L1 125 ULCER#3941 DRUG#L2 40 ULCER#AND DRUG#=S MISOPROSTOLL3 3 MISOPROSTOL=S L3 AND L1 125 ULCER#3941 DRUG#L4 1 L3 AND L12022/12/1536REGISTRY L-Numbered Answer SetsnREGISTRY L-Numbered Answer SetsnDatabase with S

44、earchable CAS RNsn=FILE REGISTRYn=S Chemical Name/CNnL1 n“Chemical Name/CN”n=FILE Database1(CAS RNs Searchable)n=S L1nDatabase Not Containing Searchable CAS RNsn=FILE REGISTRYn=S Chemical Name/CNnL1 n“Chemical Name/CN”nSELECT Namen=FILE Database2(CAS RNs non-Searchable)n=S E#2022/12/1537=FILE LREGIS

45、TRY=S Enalapril acid 3 ENALAPRIL 31528 ACIDL1 1 ENALAPRIL ACID (ENALAPRIL(W)ACID)=D L1L1 ANSWER 1 OF 1 COPYRIGHT 2000 ACSRN 76420-72-9 LREGISTRYCN L-Proline,N-(1S)-1-carboxy-3-phenylpropyl-L-alanyl-(9CI)(CA INDEX NAME)OTHER CA INDEX NAMES:CN L-Proline,1-N-(1-carboxy-3-phenylpropyl)-L-alanyl-,(S)-OTH

46、ER NAMES:CN Enalapril acidCN Enalapril diacidCN EnalaprilatCN MK 422CN N-1(S)-Carboxy-3-phenylpropyl-L-alanyl-L-prolineFS STEREOSEARCHMF C18 H24 N2 O5CI COMLC STN Files:AGRICOLA,ANABSTR,BEILSTEIN*,BIOBUSINESS,BIOSIS,(*File contains numerically searchable property data)Absolute stereochemistry.=FILE

47、LCA=S L1L2 3 L12022/12/1538SELECT n格式=SELECT L#extraction field answer or term numbersn例子=SELECT L1 CN 1-nextraction field*:nCN(Chemical Name)nRN(Registry Number)nAU(author)nTI(Title)*Database dependable2022/12/1539=SELECT CN 1-ENTER ANSWER SET OR SMARTSELECT L#OR(L2):L1E1 THROUGH E9 ASSIGNED=D SELE

48、CTE1 1 ENALAPRIL ACID/CNE2 1 ENALAPRIL DIACID/CNE3 1 ENALAPRILAT/CNE4 1 ENALAPRILIC ACID/CNE5 1 L-PROLINE,N-(1S)-1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL-/CNE6 1 L-PROLINE,1-(N-(1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-,(S)-/CNE7 1 MK 421 DIACID/CNE8 1 MK 422/CNE9 1 N-(1(S)-CARBOXY-3-PHENYLPROPYL)-L-ALANYL-L-P

49、ROLINE/CN=FILE LMEDLINE=S E1-E9 0 ENALAPRIL ACID/CN 0 ENALAPRIL DIACID/CN 1 ENALAPRILAT/CN 0 ENALAPRILIC ACID/CN 0 L-PROLINE,N-(1S)-1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL-/CN 0 L-PROLINE,1-(N-(1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-,(S)-/CN 0 MK 421 DIACID/CN 0 MK 422/CN 0 N-(1(S)-CARBOXY-3-PHENYLPROPYL)-L

50、-ALANYL-L-PROLINE/CNL3 1(ENALAPRIL ACID/CN OR ENALAPRIL DIACID/CN OR ENALAPRILAT/CN OR ENALAPRILIC ACID/CN OR L-PROLINE,N-(1S)-1-CARBOXY-3-PHEN YLPROPYL)-L-ALANYL-/CN OR L-PROLINE,1-(N-(1-CARBOXY-3-PHENYLP ROPYL)-L-ALANYL)-,(S)-/CN OR MK 421 DIACID/CN OR MK 422/CN OR N-(1(S)-CARBOXY-3-PHENYLPROPYL)-